target eye drops maximum redness relief eye

Generic: glycerin, naphazoline hydrochloride

Labeler: target corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name target eye drops maximum redness relief eye
Generic Name glycerin, naphazoline hydrochloride
Labeler target corporation
Dosage Form SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

glycerin 500 mg/100mL, naphazoline hydrochloride 30 mg/100mL

Manufacturer
Target Corporation

Identifiers & Regulatory

Product NDC 11673-100
Product ID 11673-100_0cfa0b71-d377-fa73-e063-6294a90a390e
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M018
Listing Expiration 2026-12-31
Marketing Start 2019-02-08

Pharmacologic Class

Established (EPC)
non-standardized chemical allergen [epc]
Chemical Structure
allergens [cs] glycerol [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe] increased igg production [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 11673100
Hyphenated Format 11673-100

Supplemental Identifiers

RxCUI
1235200
UNII
PDC6A3C0OX MZ1131787D
NUI
N0000185370 N0000175629 N0000184306 N0000185001 M0000728 M0009417

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name target eye drops maximum redness relief eye (source: ndc)
Generic Name glycerin, naphazoline hydrochloride (source: ndc)
Application Number M018 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 500 mg/100mL
  • 30 mg/100mL
source: ndc
Packaging
  • 1 BOTTLE, DROPPER in 1 BOX (11673-100-01) / 15 mL in 1 BOTTLE, DROPPER
source: ndc

Packages (1)

11673-100-01 1 BOTTLE, DROPPER in 1 BOX (11673-100-01) / 15 mL in 1 BOTTLE, DROPPER

Ingredients (2)

glycerin (500 mg/100mL) naphazoline hydrochloride (30 mg/100mL)

Linked Drug Pages (1)

Target Eye Drops Maximum Redness Relief Eye ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "0cfa0b71-d377-fa73-e063-6294a90a390e", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "unii": ["PDC6A3C0OX", "MZ1131787D"], "rxcui": ["1235200"], "spl_set_id": ["1b26cd3b-4a05-4623-b320-01f22b3106ff"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, DROPPER in 1 BOX (11673-100-01)  / 15 mL in 1 BOTTLE, DROPPER", "package_ndc": "11673-100-01", "marketing_start_date": "20190208"}], "brand_name": "Target Eye Drops Maximum Redness Relief Eye", "product_id": "11673-100_0cfa0b71-d377-fa73-e063-6294a90a390e", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Non-Standardized Chemical Allergen [EPC]"], "product_ndc": "11673-100", "generic_name": "Glycerin, Naphazoline hydrochloride", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Target Eye Drops Maximum Redness Relief Eye", "active_ingredients": [{"name": "GLYCERIN", "strength": "500 mg/100mL"}, {"name": "NAPHAZOLINE HYDROCHLORIDE", "strength": "30 mg/100mL"}], "application_number": "M018", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190208", "listing_expiration_date": "20261231"}